# A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF

> **NCT03925194** · PHASE2 · RECRUITING · sponsor: **Heidelberg University** · enrollment: 52 (estimated)

## Conditions studied

- Cystic Fibrosis, 10011762

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT03925194
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03925194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03925194, "A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03925194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*